Progressive Supranuclear Palsy Market - Global Industry Analysis, Size, Share, Trends And Forecast,

Page 1

Single User License: Progressive Supranuclear Palsy Market Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020

Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

USD 4315.5   

Flat 10% Discount!!

Report will be delivered with in 15-20 working days

Free Customization as per your requirement You will get Custom Report at Syndicated Report price

Request Sample

Buy Now


REPORT DESCRIPTION

Palsy is a class of neuro-degenerative disorders affecting many people worldwide. Frequently seen among the geriatric population, palsy is not necessarily endemic to older generation or a specific race, infact they have also been reported in much younger populations, although the reason may be different (trauma/abuse). Progressive supranuclear palsy is a type of palsy, specific to older populations, wherein certain sections of the brain die due to various, yet unknown reasons. The most plausible explanation for PSP found is the variation in the tau protein synthesis that leads to collapse of neurological cells in the brain. Browse Full Report with TOC: http://www.transparencymarketresearch.com/progressive-supranuclearpalsy.html The prominence of this factor has been studied in many patients, however it hasn’t been accepted as the primary cause for PSP, instead scientists believe tau protein variation may play an assisting role in PSP. The initial symptoms of PSP are similar to Parkinson’s disease, which involves frequent loss of balance, forward stoop, frequent collisions while walking, etc. Visual symptoms, i.e. nystagmus, inability to frequently close eyelids, difficult in focusing near objects, double vision and difficulty in moving eye in a vertical axis, are some of the primary symptoms that differentiate palsy from Parkinson’s disease. In the later stages a patient may exhibit behavioral changes, dementia, swallowing difficulties and speech slurring, to name a few. In extreme cases, paralysis and inability to move the neck is also reportedly seen. PSP is confirmed with an MRI of the brain, where brain clots or decay show affirmative signs. PSP diagnosed patients often have a window of 410 years, on an average 7 years until their death. The disorder has the prefix “Progressive” for the very same reason that PSP once diagnosed, is sure to result in total brain death for the patient in the near future.


Treatments or cure for PSP do not exist as of date, symptomatic relief can however be provided to patients to ease their discomfort and pain. Treatment wise patients are segregated into levodopa responsive (in case Parkinsonism is accompanied with PSP) and levodopa unresponsive. Sometimes levodopa unresponsiveness is also used as a differentiating test for PSP from Parkinson’s, however a majority of medical practitioners believe both conditions can coexist in individuals. Migraine medications are given to ease headaches, which are frequent and cause much discomfort later on. OnabotulinumtoxinA is also administered as injections to ease dystonia and muscle rigidity. Methylcellulose eye drops are administered to patients with conjunctivitis, this is because PSP patients’ exhibit lower eyelid blink rate, thereby increasing their susceptibility to eye infection. The prevalence of PSP is moderately high, with various statistics showing occurrence among one in 16,000 to one in 100,000. Many famous celebrity cases of PSP has generated interest in the market worldwide, developed nations are the best in diagnosing patients with PSP, whereas in developing nations patients are usually confused or broadly labeled as regular palsy. The market for PSP therefore lies majorly in North Americas and Europe. Product wise the sales of Parkinson’s disease medicines have seen large sales in the Asia-Pacific region, together with migraine treatments and eye infections market. Large populations have been observed to be the major cause, as PSP and Parkinson’s have no racial or genotypic specificities. Rehabilitation centers and nursing homes for PSP patients have seen success in the U.S and Europe along with Canada and Australia. Such centers are on the rise recently in Asia too. Some of the major manufacturers of levodopa/carbidopa are: Merck & Co, Aton Pharmaceuticals Inc., Bristol Myers Squibb Co., etc. Migraine drugs include anti-inflammatory and pain management drugs, some of these manufacturers include: GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceutical Industries Ltd., etc. This research report analyzes this market depending on its market segments, major geographies, and current market trends.


This report provides comprehensive analysis of 

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

Reasons for Buying this Report 

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making indepth analysis of market segments

It provides distinctive graphics and exemplified SWOT analysis of major market segments

More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceuticalmarket-reports-1.html


About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse Market Research Blogs: http://www.tmrblog.com/ https://marketingfirmblog.wordpress.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.